Pinaverium bromide

Pinaverium bromide (CAS 53251-94-8), also marketed as Dicetel, is a quaternary ammonium compound used as an antispasmodic active pharmaceutical ingredient targeting gastrointestinal smooth muscle.

It is the active substance in finished dosage forms prescribed for irritable bowel syndrome and other functional bowel disorders. As an API, it is the core ingredient in oral solid dosage manufacturing.

This compound is primarily used in film-coated tablets formulated for gastrointestinal indications. Contract manufacturers and generic drug producers source it to develop bioequivalent products where the reference listed drug contains Dicetel.

Formulators working in regulated markets across Latin America, Europe, and Asia procure it under strict pharmacopoeial-aligned specifications to meet registration requirements. It is also relevant to research organizations.

These organizations conduct GI motility studies requiring a characterized reference standard. The material is supplied as a white to off-white crystalline powder available in pharmaceutical-grade quality.

The product is aligned with in-house or customer-specific specifications, as no widely adopted compendial monograph (USP/Ph.Eur.) is broadly published for this specific compound.

Packaging is typically offered in kilogram-scale quantities suited to clinical batch manufacturing and commercial API supply chains. This ensures reliable delivery for large-scale pharmaceutical production needs.